A Pennsylvania jury has awarded $3 million to a couple who alleged their child’s birth defects were caused by in vitro exposure to Janssen Pharmaceutical Inc.’s anti-seizure drug Topamax. Janssen is a division of Johnson & Johnson.
The...
Saxagliptin Marketed as Onglyza and Kombiglyze XR
The U.S. Food and Drug Administration (FDA) has announced it is conducting an investigation into saxagliptin (marketed as Onglyza and Kombiglyze XR) specifically looking into a possible link between the diabetes drug and an increased risk of...
Lack of Training, Access to Sanitizer Continue to Thwart Hospital Safety
Despite the fact it’s one of the main ways to prevent the spread of bacteria and germs, a new study indicates that hand hygiene isn’t always a focus of training in healthcare facilities. As result, patients could be at serious risk; each year...